Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
Clinical trial NCT04774445 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04774445
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-03
- Primary completion
- 2025-04-30
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.